Pedido rápido

IFN-alpha / IFNA1 / IFN Anticuerpo, Mabs de ratón

    Hoja de datosReseñasProductos relacionadosProtocolos
    Rata IFNA1 Información de producto de anticuerpo
    Inmunogen:Recombinant Rat IFN-alpha / IFNA1 / IFN protein (Catalog#80174-R08H)
    Clone ID:02
    Tipo de Ig:Mouse IgG1
    Concentración:
    Endotoxina:
    Formulación:0.2 μm filtered solution in PBS
    Preparación:This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Rat IFN-alpha / IFNA1 / IFN (rh IFN-alpha / IFNA1 / IFN; Catalog#80174-R08H; P05011; Met1-Ser192). The IgG fraction of the cell culture supernatant was purified by Protein A affinity.
    Other IFNA1 Antibody Products
    IFN-alpha / IFNA1 / IFN Fondo

    IFNA1, also known as IFN-alpha and IFNA, belongs to the alpha/beta interferon family. Interferons(IFNs) are proteins made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites or tumor cells. They belong to the large class of glycoproteins known as cytokines. IFNs stimulate the production of two enzymes: a protein kinase and an oligoadenylate synthetase. They allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors. IFNs can activate immune cells, such as natural killer cells and macrophages; they increase recognition of infection or tumor cells by up-regulating antigen presentation to T lymphocytes; and they also increase the ability of uninfected host cells to resist new infection by virus.Leukocyte interferon is produced predominantly by B lymphocytes. Immune interferon is produced by mitogen- or antigen-stimulated T lymphocytes. IFNA1 is produced by macrophages and has antiviral activities.

    Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

    Rata IFN-alpha / IFNA1 / IFN Referencias
  • Takayama I, et al. (2012) The nucleocapsid protein of measles virus blocks host interferon response. Virology. 424(1):45-55.
  • Vairo D, et al. (2011) Severe impairment of IFN-? and IFN-? responses in cells of a patient with a novel STAT1 splicing mutation. Blood. 118(7):1806-17.
  • Bhattacharya S, et al. (2011) Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFN? via accelerating the degradation of its receptor. Blood. 118(15):4179-87.
  • Product nameProduct name
    Size / Price
    Catálogo: 80174-MM02-100
    Precio de lista: 
    Precio:      (You Save: )

    Datasheet & Documentation

    All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
    Nota: Todos los productos son "PARA SU USO ÚNICAMENTE EN INVESTIGACIÓN Y NO INDICADOS PARA SU USO DIAGNÓSTICO O TERAPÉUTICO"